WEBULL
News
CELU
1.300
+11.11%
0.130
Weekly Report: what happened at CELU last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at CELU last week (0119-0123)?
Weekly Report · 01/26 10:05
Celularity Extends Severance and Equity Vesting for Senior Executive John Haines
Reuters · 01/21 21:31
Weekly Report: what happened at CELU last week (0112-0116)?
Weekly Report · 01/19 10:10
Weekly Report: what happened at CELU last week (0105-0109)?
Weekly Report · 01/12 10:09
Weekly Report: what happened at CELU last week (1229-0102)?
Weekly Report · 01/05 10:04
Celularity files to sell 14.08M shares of Class A common stock for holders
TipRanks · 12/31/2025 21:20
Celularity Files Prospectus For The Offering Of Up To 14.1M Shares Of Class A Common Stock
Benzinga · 12/31/2025 21:19
CELULARITY INC - FILES FOR OFFERING OF UP TO 14.1 MLN SHARES OF CLASS A COMMON STOCK - SEC FILING
Reuters · 12/31/2025 21:16
Celularity's Biovance, Biovance 3L To Remain Eligible For Med. Coverage Under Withdrawn LCDs
NASDAQ · 12/29/2025 12:10
Weekly Report: what happened at CELU last week (1222-1226)?
Weekly Report · 12/29/2025 10:04
Organogenesis, MiMedx among decliners as Medicare to pull skin substitute LCDs
Seeking Alpha · 12/26/2025 15:41
Celularity CEO Welcomes CMS Withdrawal of Skin Substitute LCDs
Reuters · 12/26/2025 13:30
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
Barchart · 12/26/2025 07:30
Celularity Secures New Financing To Support Strategic Shift
TipRanks · 12/23/2025 22:01
CELULARITY ANNOUNCES CLOSING OF FINANCING TRANSACTIONS
Reuters · 12/22/2025 21:01
Press Release: Celularity Announces Closing of Financing Transactions
Dow Jones · 12/22/2025 21:01
Weekly Report: what happened at CELU last week (1215-1219)?
Weekly Report · 12/22/2025 10:04
Celularity Shareholders Reject Expansion of Equity Incentive Plan
TipRanks · 12/19/2025 21:58
Celularity files to sell 15.95M shares of Class A common stock for holders
TipRanks · 12/19/2025 21:20
More
Webull provides a variety of real-time CELU stock news. You can receive the latest news about Celularity Inc through multiple platforms. This information may help you make smarter investment decisions.
About CELU
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.